FDA Warns Against Use Of Needle-Free Devices With Dermal Fillers
The agency’s warning says that needle-free dermal filler “pens” sold on social media could pose a serious risk to consumers.
You may also be interested in...
Physicians on the panel backed suggestions including improved labeling, broadening the patient pool for clinical trials, and more thoroughly tracking adverse events.
Benjamin Wallfisch, a senior attorney at the Office of the Inspector General in the US Department of Health and Human Services, recently discussed how companies can avoid apparent violations of anti-kickback law while hosting educational programs.
Brainsgate’s ISS500 can reportedly lessen stroke symptoms if put into use within 24 hours of the onset of symptoms.